Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
Intellia to cut workforce by 27%, plans commercialization of first CRISPR therapy in 2027
6 months ago
People
Versant unveils Light Horse with $62M and a partnership with Novartis
6 months ago
Financing
Deals
Leyden Labs gets $70M to test if nasal sprays can help protect against viruses
6 months ago
Deals
Coronavirus
Coave raises €32M Series A despite being two years away from the clinic
6 months ago
Financing
Aiolos team reunites with $411M for new biotech with obesity drugs from China
6 months ago
Financing
R&D
Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic
6 months ago
People
Solid Bio's former CEO launches new rare disease startup with €65M Series A
6 months ago
Financing
Roche's Chugai partners with Swiss ADC biotech Araris
6 months ago
Deals
Pharma
ARCH, F-Prime and Mubadala pump $200M into former Denali programs
6 months ago
Financing
Exclusive: GV-backed startup Prudentia launches with $7M to help pharma make better deals, faster
6 months ago
Financing
AI
Novo expands pact with Flagship's Valo to include obesity, diabetes for $190M near-term
6 months ago
Deals
Maze files for first biotech IPO of 2025, following $115M funding boost
6 months ago
Financing
Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio
6 months ago
Deals
China
Exclusive: Forbion-backed cardio biotech rebrands to RyCarma with Phase 2 plans
6 months ago
People
'Microprotein' biotech Velia, backed by TCG and Foresite, to wind down
6 months ago
People
Exclusive: Joe Jimenez's Aditum Bio rings in new year with $428M third fund
6 months ago
Financing
Exclusive: AI biotech Iambic snags CFO who helped steer Recursion-Exscientia deal
6 months ago
People
AI
Regeneron buys London-based ocular biotech
6 months ago
Deals
Pharma
A look at biotech's year of the megaround
6 months ago
Financing
Immunology biotech Inmagene to join Nasdaq through reverse merger with what's left of Ikena
6 months ago
Deals
Sofinnova outlines $550M fund after IPOs and M&A deals
6 months ago
Financing
Exclusive: Florida cancer biotech raises $100M Series A
6 months ago
Financing
David Epstein gets $140M for Ottimo's bifunctional take on hot PD-1xVEGF field
6 months ago
Financing
Updated: Flagship gene therapy startup Ring Therapeutics nearly halves workforce as CEO departs
6 months ago
People
Cell/Gene Tx
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page